論文 |
papers |
-
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction. Yuki Otsuka,Keiko Imamura,Akio Oishi,Kazuhide Asakawa,Takayuki Kondo,Risako Nakai,Mika Suga,Ikuyo Inoue,Yukako Sagara,Kayoko Tsukita,Kaori Teranaka,Yu Nishimura,Akira Watanabe,Kazuhiro Umeyama,Nanako Okushima,Kohnosuke Mitani,Hiroshi Nagashima,Koichi Kawakami,Keiko Muguruma,Akitaka Tsujikawa,Haruhisa Inoue JCI insight 9巻8号 2024年04月22日
-
Paracentral acute middle maculopathy in systemic sclerosis and subsequent branch retinal artery occlusion. Miki Takao,Akio Oishi,Toshimasa Shimizu,Yutaka Kuwatsuka,Takashi Kitaoka American journal of ophthalmology case reports 32巻101955頁-101955頁 2023年12月
-
MACULAR CHORIORETINAL ATROPHY AND VISUAL OUTCOMES IN RANIBIZUMAB- OR AFLIBERCEPT-TREATED MYOPIC CHOROIDAL NEOVASCULARIZATION. Yu Kawashima,Masayuki Hata,Masahiro Miyake,Mami Kusaka,Akio Oishi,Sotaro Ooto,Hiroshi Tamura,Manabu Miyata,Akihito Uji,Naoko Ueda-Arakawa,Ayako Takahashi,Akitaka Tsujikawa Retina (Philadelphia, Pa.) 2023年09月06日
-
Ten-year visual outcome and change in chorioretinal atrophy after intravitreal ranibizumab for macular neovascularization in pathologic myopia. Ryo Sakata,Manabu Miyata,Sotaro Ooto,Hiroshi Tamura,Naoko Ueda-Arakawa,Yuki Muraoka,Masahiro Miyake,Masayuki Hata,Ayako Takahashi,Ai Kido,Shogo Numa,Yuki Mori,Kanae Tsuda,Akihito Uji,Akio Oishi,Akitaka Tsujikawa Retina (Philadelphia, Pa.) 43巻11号1863頁-1871頁 2023年06月16日
-
Estimation of Visual Function Using Deep Learning From Ultra-Widefield Fundus Images of Eyes With Retinitis Pigmentosa. Daisuke Nagasato,Takahiro Sogawa,Mao Tanabe,Hitoshi Tabuchi,Shogo Numa,Akio Oishi,Hanako Ohashi Ikeda,Akitaka Tsujikawa,Tadao Maeda,Masayo Takahashi,Nana Ito,Gen Miura,Terumi Shinohara,Mariko Egawa,Yoshinori Mitamura JAMA ophthalmology 141巻4号305頁-313頁 2023年02月23日
-
Investigation of incidence and causes of acute vision loss during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration during a 4-year follow-up. Akira Machida,Akio Oishi,Eiko Tsuiki,Yuki Maekawa,Junko Kurihara,Yuki Hirata,Eriko Machida,Takashi Kitaoka Retina (Philadelphia, Pa.) 2023年01月18日
-
Geometric Morphometrics Can Predict Postoperative Visual Acuity Changes in Patients With Epiretinal Membrane: A Retrospective Study. Sugao Miyagi,Akio Oishi,Eiko Tsuiki,Takashi Kitaoka Translational vision science & technology 12巻1号24頁-24頁 2023年01月03日
-
Investigating the clinical validity of the guided progression analysis definition with 10-2 visual field in retinitis pigmentosa. Shotaro Asano,Ryo Asaoka,Akio Oishi,Yuri Fujino,Hiroshi Murata,Keiko Azuma,Manabu Miyata,Ryo Obata,Tatsuya Inoue PloS one 18巻9号e0291208頁- 2023年
-
Optic disc hemorrhage in a young female following mRNA coronavirus disease 2019 vaccination: a case report. Kyohei Tsuda,Akio Oishi,Takashi Kitaoka Journal of medical case reports 16巻1号462頁-462頁 2022年12月08日
-
Re: Singh et al: Efficacy outcomes of brolucizumab versus aflibercept in neovascular age-related macular degeneration patients with early residual fluid (Ophthalmol Retina. 2022;6:377-386). Akio Oishi,Yuki Maekawa,Takashi Kitaoka Ophthalmology. Retina 6巻12号1264頁-1264頁 2022年12月
-
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction. Yuki Otsuka,Keiko Imamura,Akio Oishi,Kazuhide Asakawa,Takayuki Kondo,Risako Nakai,Mika Suga,Ikuyo Inoue,Yukako Sagara,Kayoko Tsukita,Kaori Teranaka,Yu Nishimura,Akira Watanabe,Kazuhiro Umeyama,Nanako Okushima,Kohnosuke Mitani,Hiroshi Nagashima,Koichi Kawakami,Keiko Muguruma,Akitaka Tsujikawa,Haruhisa Inoue JCI insight 9.8. 2024/04/22
-
Paracentral acute middle maculopathy in systemic sclerosis and subsequent branch retinal artery occlusion. Miki Takao,Akio Oishi,Toshimasa Shimizu,Yutaka Kuwatsuka,Takashi Kitaoka American journal of ophthalmology case reports 32.101955-101955 2023/12
-
MACULAR CHORIORETINAL ATROPHY AND VISUAL OUTCOMES IN RANIBIZUMAB- OR AFLIBERCEPT-TREATED MYOPIC CHOROIDAL NEOVASCULARIZATION. Yu Kawashima,Masayuki Hata,Masahiro Miyake,Mami Kusaka,Akio Oishi,Sotaro Ooto,Hiroshi Tamura,Manabu Miyata,Akihito Uji,Naoko Ueda-Arakawa,Ayako Takahashi,Akitaka Tsujikawa Retina (Philadelphia, Pa.) 2023/09/06
-
Ten-year visual outcome and change in chorioretinal atrophy after intravitreal ranibizumab for macular neovascularization in pathologic myopia. Ryo Sakata,Manabu Miyata,Sotaro Ooto,Hiroshi Tamura,Naoko Ueda-Arakawa,Yuki Muraoka,Masahiro Miyake,Masayuki Hata,Ayako Takahashi,Ai Kido,Shogo Numa,Yuki Mori,Kanae Tsuda,Akihito Uji,Akio Oishi,Akitaka Tsujikawa Retina (Philadelphia, Pa.) 43.11.1863-1871 2023/06/16
-
Estimation of Visual Function Using Deep Learning From Ultra-Widefield Fundus Images of Eyes With Retinitis Pigmentosa. Daisuke Nagasato,Takahiro Sogawa,Mao Tanabe,Hitoshi Tabuchi,Shogo Numa,Akio Oishi,Hanako Ohashi Ikeda,Akitaka Tsujikawa,Tadao Maeda,Masayo Takahashi,Nana Ito,Gen Miura,Terumi Shinohara,Mariko Egawa,Yoshinori Mitamura JAMA ophthalmology 141.4.305-313 2023/02/23
-
Investigation of incidence and causes of acute vision loss during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration during a 4-year follow-up. Akira Machida,Akio Oishi,Eiko Tsuiki,Yuki Maekawa,Junko Kurihara,Yuki Hirata,Eriko Machida,Takashi Kitaoka Retina (Philadelphia, Pa.) 2023/01/18
-
Geometric Morphometrics Can Predict Postoperative Visual Acuity Changes in Patients With Epiretinal Membrane: A Retrospective Study. Sugao Miyagi,Akio Oishi,Eiko Tsuiki,Takashi Kitaoka Translational vision science & technology 12.1.24-24 2023/01/03
-
Investigating the clinical validity of the guided progression analysis definition with 10-2 visual field in retinitis pigmentosa. Shotaro Asano,Ryo Asaoka,Akio Oishi,Yuri Fujino,Hiroshi Murata,Keiko Azuma,Manabu Miyata,Ryo Obata,Tatsuya Inoue PloS one 18.9.e0291208- 2023
-
Optic disc hemorrhage in a young female following mRNA coronavirus disease 2019 vaccination: a case report. Kyohei Tsuda,Akio Oishi,Takashi Kitaoka Journal of medical case reports 16.1.462-462 2022/12/08
-
Re: Singh et al: Efficacy outcomes of brolucizumab versus aflibercept in neovascular age-related macular degeneration patients with early residual fluid (Ophthalmol Retina. 2022;6:377-386). Akio Oishi,Yuki Maekawa,Takashi Kitaoka Ophthalmology. Retina 6.12.1264-1264 2022/12
|